HDFC Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹236 Cr | ₹1936 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 08 Nov 2021 | 04 Oct 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Dhruv Muchhal |
ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Month | -1.92% | -1.06% |
6 Month | 8.07% | 13.53% |
1 Year | 3.3% | 15.3% |
3 Year | 21.21% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
6 Month | 2.6% | 6.63% |
1 Year | 1.34% | 15.08% |
3 Year | 20.4% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Year | 19.5% | 29.56% |
3 Year | 19.53% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Standard Deviation | 15.16% | - |
Sharp | 0.98% | - |
Beta | 0.94% | - |
Alpha | -1.87% | - |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Name | Rohan Korde | Dhruv Muchhal |
Total AUM | ₹4626 Cr | ₹520687 Cr |
Funds Managed | 10 | 40 |
ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 3.17 | 8.44 |
Mid Cap | 37.04 | 24.57 |
Small Cap | 32.68 | 37.01 |
Large Cap | 27.1 | 29.99 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 1.29 | 1.8 |
Healthcare | 91.09 | 95.93 |
Basic Materials | 5.09 | 2.27 |
Industrials | 1.81 | - |
Financial Services | 0.73 | - |
Top Comparisons
ICICI Prudential Silver ETF Fund of Fund - Growth
3Y Returns24.44%
Kotak Silver ETF Fund of Fund - Regular Plan - Growth Option
3Y Returns0%
HSBC Ultra Short Duration Fund - Regular Growth
3Y Returns7.1%
Axis Ultra Short Duration Fund - Regular Plan Growth
3Y Returns6.68%
Canara Robeco Equity Hybrid Fund - Regular Plan - Growth Option
3Y Returns13.52%
Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth
3Y Returns13.09%
Nippon India Growth Mid Cap Fund-Growth Plan-Growth Option
3Y Returns25.52%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns23.64%